Evidence map›Paper›PMID 26998194›Full record

ArticleOxidative medicine and cellular longevity2016

Lung Neutrophilia in Myeloperoxidase Deficient Mice during the Course of Acute Pulmonary Inflammation.

Silvie Kremserova, Tomas Perecko, Karel Soucek, Anna Klinke, Stephan Baldus, Jason P Eiserich, Lukas Kubala

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Comparison of anti-inflammatory effects ofChinese herbal medicines · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Silvie KremserovaDepartment of Free Radical Pathophysiology, Institute of Biophysics, Academy of Sciences of the Czech Republic, 61265 Brno, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, 61137 Brno, Czech Republic; International Clinical Research Center, Center of Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, 65691 Brno, Czech Republic.
Tomas PereckoDepartment of Free Radical Pathophysiology, Institute of Biophysics, Academy of Sciences of the Czech Republic, 61265 Brno, Czech Republic; International Clinical Research Center, Center of Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, 65691 Brno, Czech Republic.
Karel SoucekInternational Clinical Research Center, Center of Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, 65691 Brno, Czech Republic; Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, 61265 Brno, Czech Republic.
Anna KlinkeInternational Clinical Research Center, Center of Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, 65691 Brno, Czech Republic; Heart Center, University of Cologne, 50937 Cologne, Germany.
Stephan BaldusHeart Center, University of Cologne, 50937 Cologne, Germany.
Jason P EiserichDepartment of Internal Medicine, School of Medicine, University of California, Davis, CA 95616, USA.
Lukas KubalaDepartment of Free Radical Pathophysiology, Institute of Biophysics, Academy of Sciences of the Czech Republic, 61265 Brno, Czech Republic; International Clinical Research Center, Center of Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, 65691 Brno, Czech Republic.
Czech Academy of Sciences, Institute of Biophysics · CZSt. Anne's University Hospital Brno · CZUniversity Hospital Brno · CZUniversity of California, Davis · USUniversity of Cologne · DE

Funding

Therapeutic Targeting of Myeloperoxidase in Acute InflammationR21HL092506 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CROSS, CARROLL E · 2009 to 2011
$416k
NHLBI NIH HHS HL092506NHLBI NIH HHS R21 HL092506
6 · The paper itself

Abstract

Systemic inflammation accompanying diseases such as sepsis affects primarily lungs and induces their failure. This remains the most common cause of sepsis induced mortality. While neutrophils play a key role in pulmonary failure, the mechanisms remain incompletely characterized. We report that myeloperoxidase (MPO), abundant enzyme in neutrophil granules, modulates the course of acute pulmonary inflammatory responses induced by intranasal application of lipopolysaccharide. MPO deficient mice had significantly increased numbers of airway infiltrated neutrophils compared to wild-type mice during the whole course of lung inflammation. This was accompanied by higher levels of RANTES in bronchoalveolar lavage fluid from the MPO deficient mice. Other markers of lung injury and inflammation, which contribute to recruitment of neutrophils into the inflamed lungs, including total protein and other selected proinflammatory cytokines did not significantly differ in bronchoalveolar lavage fluid from the wild-type and the MPO deficient mice. Interestingly, MPO deficient neutrophils revealed a decreased rate of cell death characterized by phosphatidylserine surface expression. Collectively, the importance of MPO in regulation of pulmonary inflammation, independent of its putative microbicidal functions, can be potentially linked to MPO ability to modulate the life span of neutrophils and to affect accumulation of chemotactic factors at the inflammatory site.

Indexed as

Acute DiseaseAcute Lung InjuryAnimalsLeukocyte DisordersLipopolysaccharidesMaleMetabolism, Inborn ErrorsMiceMice, Inbred C57BLMice, KnockoutNeutrophilsPeroxidasePneumoniaLipopolysaccharidesPeroxidase

Identifiers

PMID26998194
PMCPMC4779540
OpenAlexW2286215981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.